U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.265T>C (p.Cys89Arg) AND Tyrosinase-negative oculocutaneous albinism

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
May 16, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000003984.11

Allele description [Variation Report for NM_000372.5(TYR):c.265T>C (p.Cys89Arg)]

NM_000372.5(TYR):c.265T>C (p.Cys89Arg)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.265T>C (p.Cys89Arg)
HGVS:
  • NC_000011.10:g.89178218T>C
  • NG_008748.1:g.5347T>C
  • NM_000372.5:c.265T>CMANE SELECT
  • NP_000363.1:p.Cys89Arg
  • NC_000011.9:g.88911386T>C
  • NM_000372.4:c.265T>C
  • P14679:p.Cys89Arg
Protein change:
C89R; CYS89ARG
Links:
UniProtKB: P14679#VAR_007659; OMIM: 606933.0011; dbSNP: rs28940877
NCBI 1000 Genomes Browser:
rs28940877
Molecular consequence:
  • NM_000372.5:c.265T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Tyrosinase-negative oculocutaneous albinism (OCA1A)
Synonyms:
Oculocutaneous albinism type 1A; Albinism, oculocutaneous, type IA
Identifiers:
MONDO: MONDO:0008745; MedGen: C4551504; Orphanet: 352731; Orphanet: 79431; OMIM: 203100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000024150OMIM
no assertion criteria provided
Pathogenic
(Feb 3, 2020)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001368679Centre for Mendelian Genomics, University Medical Centre Ljubljana
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 7, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001821925Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 22, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002579976MGZ Medical Genetics Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 16, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

RFLP for TaqI at the human tyrosinase locus.

Spritz R, Strunk K, Oetting W, King R.

Nucleic Acids Res. 1988 Oct 25;16(20):9890. No abstract available.

PubMed [citation]
PMID:
2903492
PMCID:
PMC338818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000024150.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In an American black with classic, tyrosinase-negative oculocutaneous albinism (OCA1A; 203100), Spritz et al. (1991) identified substitution of arginine for cysteine at codon 89. The subject was homozygous for a TGC-to-CGC transition.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Centre for Mendelian Genomics, University Medical Centre Ljubljana, SCV001368679.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS3,PM2,PP3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV001821925.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From MGZ Medical Genetics Center, SCV002579976.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024